Fusion Pharmaceuticals Inc.

NASDAQ:FUSN

21.55 (USD) • At close June 3, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -33.67-28.179-17.252-25.175-24.291-24.617-24.013-19.073-19.909-17.236-19.429-26.853-17.529-13.385-9.993-44.733-10.222-8.206-0.594-3.456-3.933
Depreciation & Amortization 0.3610.3610.3740.3370.2730.2480.2420.2160.2030.1840.1850.1540.1110.1090.1030.0980.1720.0770.0790.0710.063
Deferred Income Tax -0.4052.918-0.882-0.696-0.494-0.651-1.918-0.253-0.34-0.321-0.2570.0980.449-0.548-0.0046.0650.334-0.059000
Stock Based Compensation 4.5173.2552.9943.0463.1492.7782.6972.7362.6332.3662.3742.1451.7181.3431.2410.4260.3580.290.1380.0880.102
Change In Working Capital 2.3463.011-4.2523.456-3.5023.0250.016-1.3281.947-1.893-5.066-2.05-5.5863.991-4.2040.3350.6141.7910.836-0.4820.94
Accounts Receivables 0.0070.0330.0210.027-0.0280.154-0.0380.1490.031-0.057-0.1790000000000
Change In Inventory 00.00200000000.176-7.8410000000000
Change In Accounts Payables 0.4450.834-0.9980.16-0.7041.286-0.249-0.074-0.563-1.5963.1-0.341-2.3462.4080.469-1.1770.8580.0710.42-0.6460.634
Other Working Capital 1.8942.142-3.2753.2690.7321.5850.303-1.4032.479-0.416-0.146-1.709-3.241.583-4.6731.512-0.2441.720.4160.1640.306
Other Non Cash Items 4.3321.6990.179-0.552-0.57-0.1471.3510.3860.4950.5730.6839.1990.2415.408-0.01131.6121.1242.274-3.487-0.2220
Operating Cash Flow -27.306-16.935-18.839-19.584-25.435-19.364-21.625-17.316-14.971-16.327-21.51-17.307-20.596-3.082-12.868-6.197-7.62-3.833-3.028-4.001-2.828
Investing Activities:
Investments In Property Plant And Equipment -1.334-1.439-0.473-0.71-1.223-0.95-0.222-0.375-0.595-0.538-0.16-0.209-0.584-0.06-0.681-0.168-0.214-0.116-0.189-0.112-0.039
Acquisitions Net 0-48.914-13.79925.60923.30541.983-37.47-10.01600000-9.70000000
Purchases Of Investments -118.607-56.43-38.829-70.082-62.422-89.66-25.945-32.221-17.33-15.045-25.287-66.063-66.074-164.7440000000
Sales Maturities Of Investments 49.5753.17152.62844.47339.11747.67763.41542.23737.05646.47957.66469.93137.669.70000000
Other Investing Activites -69.03748.91413.799-25.609-23.305-41.98337.4710.016000009.7-54.286000000
Investing Cash Flow -70.371-4.69713.326-26.319-24.528-42.93337.2489.64119.13130.89632.2173.659-28.998-155.104-54.967-0.168-0.214-0.116-0.189-0.112-0.039
Financing Activities:
Debt Repayment -14.9150000-0.811-24.283-9.79500000-0.2210000000
Common Stock Issued 49.09656.2160.04524.44263.3720.1323.9810.0741.62700000.0560000000
Common Stock Repurchased 000001.28500000001.1050000000
Dividends Paid 000000000000000000000
Other Financing Activities 64.011145.7140.283-0.134-3.857-0.47549.2079.9140.082-0.050.0570.210.13-0.884-2.296257.849.90700052.187
Financing Cash Flow 64.01156.2160.32824.30859.5150.13128.9059.9881.709-0.050.0570.210.130.056-2.296257.849.90700052.187
Other Information:
Effect Of Forex Changes On Cash 00.0850000000-0.0170-0.0170.01700000000
Net Change In Cash -33.66634.669-5.185-21.5959.552-62.16644.5282.3135.86914.51910.764-13.455-49.447-158.13-70.131251.4752.073-3.949-3.217-4.11349.32
Cash At End Of Period 28.25961.92528.10533.2954.88545.333107.49962.97160.65854.78940.2729.50642.96192.408250.538320.66969.19467.12171.0774.28778.4